Abstract

P02.011 (2011). 18 Kaley TJ, Wen PY, Schiff D et al. Phase II trial of sunitinib (SU011248) for recurrent meningioma. Neuro Oncol. 12(Suppl. 4),

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract CT081: Tumor treating fields in combination with Bevacizumab in recurrent or progressive meningioma in a phase II study
Priya Kumthekar ... Timothy Kruser
Cancer Research | VOL. 78
Priya Kumthekar, et. al.Priya Kumthekar ... Timothy Kruser
01 Jul 2018
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers ... Michael A Vogelbaum
Journal of neurosurgery | VOL. 122
Leland Rogers, et. al.Leland Rogers ... Michael A Vogelbaum
01 Jan 2015
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
Patrick Y Wen ...
Neuro-Oncology | VOL. 11
Patrick Y Wen, et. al.Patrick Y Wen ...
01 Dec 2009
A phase II trial of PTK787/ZK 222584 (PTK787) in recurrent high-grade meningioma.
S A Grimm ... M C Chamberlain
Journal of Clinical Oncology | VOL. 29
S A Grimm, et. al.S A Grimm ... M C Chamberlain
20 May 2011
View more papers

More From: CNS Oncology

Paper Title
Journal
Date
Author
Metastatic glioblastoma to the lungs: a case report and literature review.
Carlen A Yuen ... Xiao-Tang Kong
CNS oncology | VOL. 13
Carlen A Yuen, et. al.Carlen A Yuen ... Xiao-Tang Kong
06 Jun 2024
Extracavitary primary effusion lymphoma presenting as a solitary brain mass.
Tiffany Javadi ... Shawn Kothari
CNS oncology | VOL. 13
Tiffany Javadi, et. al.Tiffany Javadi ... Shawn Kothari
06 Jun 2024
Perspectives from neuro-oncology providers on patient access to electronic records: a survey study.
Keng Lam ... Chetna Wathoo
CNS oncology | VOL. 13
Keng Lam, et. al.Keng Lam ... Chetna Wathoo
24 May 2024
BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab.
Toru Imai ... Toshiharu Hirose
CNS oncology | VOL. 13
Toru Imai, et. al.Toru Imai ... Toshiharu Hirose
20 May 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.